Healthcare services group Uniphar said it has traded in line with expectations for the first four months of the year and remains well positioned to deliver on its full year expectations.
In a trading update issued ahead of its AGM in Dublin today, chairman Maurice Pratt said that during 2022 the company continued to make significant strategic progress across each division.
He said the company enhanced its platforms through both organic investment and merger and acquisitions, adding that this will ensure continued, resilient growth through 2023 and beyond.
In today's AGM statement, Uniphar said the deal to buy the McCauley Pharmacy Group added significant capability to its higher margin retail offering.
During 2022, it also announced a multi-year investment in a new distribution facility which it said will future-proof its Supply Chain & Retail business and support future growth across the wider group.
Maurice Pratt said that sustainability continues to form a key part of Uniphar's culture and business practices, while it also improved its carbon footprint initiatives and focused on ways to further decarbonise the business during 2022.
"The continued success of the business in 2022 could not have been delivered without the commitment, ingenuity and "can-do" spirit of our Uniphar colleagues worldwide, who continued to deliver for our customers, the pharmacies, hospitals, manufacturers and patients we serve throughout 2022, while navigating the various challenges presented during the period, including unprecedented global cost inflation and supply chain disruption", he stated.
Shares in the company moved higher in Dublin trade today.
